JP2023519965A5 - - Google Patents
Info
- Publication number
- JP2023519965A5 JP2023519965A5 JP2022559518A JP2022559518A JP2023519965A5 JP 2023519965 A5 JP2023519965 A5 JP 2023519965A5 JP 2022559518 A JP2022559518 A JP 2022559518A JP 2022559518 A JP2022559518 A JP 2022559518A JP 2023519965 A5 JP2023519965 A5 JP 2023519965A5
- Authority
- JP
- Japan
- Prior art keywords
- feature
- approximately
- use described
- dextromethorphan
- bupropion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024212992A JP2025032232A (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063002132P | 2020-03-30 | 2020-03-30 | |
| US63/002,132 | 2020-03-30 | ||
| US202063016178P | 2020-04-27 | 2020-04-27 | |
| US63/016,178 | 2020-04-27 | ||
| US202063032517P | 2020-05-29 | 2020-05-29 | |
| US63/032,517 | 2020-05-29 | ||
| US202063032567P | 2020-05-30 | 2020-05-30 | |
| US63/032,567 | 2020-05-30 | ||
| US16/894,713 US10898453B2 (en) | 2013-11-05 | 2020-06-05 | Bupropion as a modulator of drug activity |
| US16/894,713 | 2020-06-05 | ||
| PCT/US2021/024718 WO2021202419A1 (en) | 2020-03-30 | 2021-03-29 | Use of bupropion and dextromethorphan combinations for treating neurological disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212992A Division JP2025032232A (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519965A JP2023519965A (ja) | 2023-05-15 |
| JP2023519965A5 true JP2023519965A5 (https=) | 2023-07-20 |
| JP7637150B2 JP7637150B2 (ja) | 2025-02-27 |
Family
ID=77930161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559518A Active JP7637150B2 (ja) | 2020-03-30 | 2021-03-29 | 神経疾患を治療するためのブプロピオンおよびデキストロメトルファンの組み合わせの使用 |
| JP2024212992A Pending JP2025032232A (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212992A Pending JP2025032232A (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4125837A4 (https=) |
| JP (2) | JP7637150B2 (https=) |
| KR (1) | KR20220161414A (https=) |
| CN (1) | CN115697314A (https=) |
| CA (1) | CA3179048A1 (https=) |
| WO (1) | WO2021202419A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11969421B2 (en) | 2013-11-05 | 2024-04-30 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11534414B2 (en) | 2013-11-05 | 2022-12-27 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12109178B2 (en) | 2013-11-05 | 2024-10-08 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12194006B2 (en) | 2013-11-05 | 2025-01-14 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11433067B2 (en) | 2013-11-05 | 2022-09-06 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12569479B2 (en) | 2016-05-25 | 2026-03-10 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12433884B2 (en) | 2020-06-05 | 2025-10-07 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| US12472156B2 (en) | 2020-06-05 | 2025-11-18 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| US20250073188A1 (en) | 2020-06-05 | 2025-03-06 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| EP4255433A4 (en) | 2020-12-01 | 2024-05-29 | Antecip Bioventures II LLC | BUPROPION AND DEXTROMETHORPHAN FOR REDUCING THE RISK OF SUICIDE IN DEPRESSED PATIENTS |
| EP4373480A4 (en) * | 2021-07-21 | 2025-05-28 | Antecip Bioventures II LLC | TREATMENT OF DEPRESSION |
| KR20250011185A (ko) * | 2022-05-17 | 2025-01-21 | 안테씨프 바이오벤쳐스 투 엘엘씨 | 우울증의 치료 |
| US12156914B2 (en) | 2022-06-30 | 2024-12-03 | Axsome Therapeutics, Inc. | Pharmaceutical compositions comprising bupropion and cysteine |
| US12036191B1 (en) | 2022-06-30 | 2024-07-16 | Antecip Bioventures Ii Llc | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan |
| US11717518B1 (en) * | 2022-06-30 | 2023-08-08 | Antecip Bioventures Ii Llc | Bupropion dosage forms with reduced food and alcohol dosing effects |
| US12194036B2 (en) | 2022-07-07 | 2025-01-14 | Antecip Bioventures Ii Llc | Combination of dextromethorphan and bupropion for treating depression |
| US11730706B1 (en) | 2022-07-07 | 2023-08-22 | Antecip Bioventures Ii Llc | Treatment of depression in certain patient populations |
| US11844797B1 (en) | 2023-04-20 | 2023-12-19 | Antecip Bioventures Ii Llc | Combination of dextromethorphan and bupropion for treating depression |
| WO2024118570A1 (en) * | 2022-11-28 | 2024-06-06 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9763932B2 (en) * | 2013-11-05 | 2017-09-19 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
| US10898453B2 (en) * | 2013-11-05 | 2021-01-26 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11234946B2 (en) * | 2013-11-05 | 2022-02-01 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US10080727B2 (en) * | 2013-11-05 | 2018-09-25 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
| US11273134B2 (en) * | 2013-11-05 | 2022-03-15 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| MY179696A (en) * | 2013-11-05 | 2020-11-11 | Antecip Bioventures Ii Llc | Compositions and methods comprising bupropion or related compounds and dextromethorphan |
| US11007189B2 (en) * | 2013-11-05 | 2021-05-18 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
-
2021
- 2021-03-29 CN CN202180038675.3A patent/CN115697314A/zh active Pending
- 2021-03-29 EP EP21779322.3A patent/EP4125837A4/en active Pending
- 2021-03-29 JP JP2022559518A patent/JP7637150B2/ja active Active
- 2021-03-29 CA CA3179048A patent/CA3179048A1/en active Pending
- 2021-03-29 WO PCT/US2021/024718 patent/WO2021202419A1/en not_active Ceased
- 2021-03-29 KR KR1020227037493A patent/KR20220161414A/ko active Pending
-
2024
- 2024-12-06 JP JP2024212992A patent/JP2025032232A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023519965A5 (https=) | ||
| JP2023041862A5 (https=) | ||
| JP2021066744A5 (ja) | ブプロピオンおよびデキストロメトルファンを含む組成物 | |
| FI3908270T3 (fi) | Faanin ja bupropionin yhdistelmä masennuksen hoitoon aasialaisilla potilailla | |
| KR20230145525A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2023541430A5 (https=) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JP2023541432A5 (https=) | ||
| JPH05213741A (ja) | デプレニル／ｌ−ドーパ／カルビドーパ含有の医薬組成物 | |
| JP2008500288A (ja) | 経口治療用化合物の供給系 | |
| Fischer et al. | Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| JP5828609B2 (ja) | 持続性解熱鎮痛消炎剤 | |
| Gupta et al. | Intermittent short duration therapy with fluconazole is effective for tinea capitis | |
| JP2016505050A5 (https=) | ||
| JP2022553888A5 (https=) | ||
| JP2023516753A5 (https=) | ||
| CA2893836C (en) | A combination medicament comprising phenylephrine and paracetamol | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| US20170087104A1 (en) | Medicament | |
| JP2024531799A5 (https=) | ||
| Miach et al. | Double‐blind cross‐over evaluation of mazindol in the treatment of obese hypertensive patients | |
| JP4896647B2 (ja) | 苦味を有する薬物を含有する口中溶解型又は咀嚼型固形内服医薬組成物 | |
| JP2024084670A5 (https=) |